HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP
SpainMedications containing this active substance
-
Hexyon injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage DIPHTHERIA TOXOID 20 UI TETANUS TOXOID 40 UI Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 40 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 8 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP 12 µg Manufacturer: Sanofi Winthrop Industrie
-
Hexyon injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage DIPHTHERIA TOXOID 20 UI TETANUS TOXOID 40 UI Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 40 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 8 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP 12 µg Manufacturer: Sanofi Winthrop Industrie